Core and Group Health

The state's new guidance sets guidelines for insurers on how those claims should be evaluated.

The regulation could represent a sweeping shift in how drug prices are set in the U.S. and potentially eliminate some of the opacity that surrounds the system.

A majority of Americans believe science has had a mostly positive effect on the quality of health care, but they're pretty evenly divided in their opinion of overall value,

Two approved cancer therapies, with price tags of hundreds of thousands of dollars, have roiled the insurance approval process, leading to delays and, in some cases, denials of coverage.

The number of patients with claims that exceeded $1 million grew by 87 percent between 2014 and 2017.

Partnerships, promotions, new hires from Unum, Neighborhood Trust Financial Partners, Benefitfocus & more.